Biobanking – Creating a Collaborative Approach between Academia & Industry

Add bookmark
In this interview Arndt Schmitz, Head of Research Biobank, Bayer Pharma AG, speaks to Andrea Charles from Pharma IQ about creating a collaborative approach between academia and industry, the associated hurdles when technology is transferred from academia to industry and measuring successful collaboration in biobanking. Pharma IQ: Why is collaboration important between the academia and industry? A Schmitz: I would say because the two sectors are complementary, and we can only achieve result...

Latest Webinars

Pharma IQ's Power List 2022: In conversation with pharma's top leaders

2022-10-18

02:00 PM - 03:00 PM BST

Join us to hear from the most influential people in pharma today, as voted for by you

A post-pandemic 3D view of the patient and supply journey

2022-06-01

04:30 PM - 05:30 PM CET

In this panel discussion with experts from 4G Clinical, THREAD Research and World Courier, learn how...

Discover how targeted radiotherapy induced toxicity can be identified with imaging

2022-04-28

01:00 PM - 02:00 PM EST

This Pharma IQ webinar with AIQ explores how AI-assisted analysis of radiological scans enhances the...

Recommended